Compound Library

Peptide Wiki

Explore our compound library — dosing protocols, mechanisms, clinical evidence, and stacking strategies for 19 research peptides.

Source your compounds from Forge Amino — independently third-party tested, 99%+ purity, QR-linked COA on every vial.

Shop Forge Amino →

Category

Search

Showing 19 of 19 peptides
Recovery & RepairPreclinical

BPC-157

A 15-amino-acid peptide that accelerates healing of tendons, ligaments, muscles, and nerves through angiogenesis and fibroblast activation.

Accelerated tendon and ligament repairEnhanced muscle recovery from trainingImproved wound healing and skin regeneration
Routes: Subcutaneous, Intramuscular, Oral
Learn more
Recovery & RepairEmerging

TB-500

A 43-amino-acid peptide that promotes systemic healing through actin regulation and endothelial cell mobilization.

Accelerated wound closure and tissue healingEnhanced cell migration and fibroblast activitySystemic anti-inflammatory response
Routes: Subcutaneous, Intramuscular
Learn more
Recovery & RepairApproved

GHK-Cu

A naturally occurring tripeptide complexed with copper that stimulates collagen synthesis and wound healing with 30+ years of clinical research.

70% increase in collagen productionImproved skin elasticity and thicknessWrinkle reduction and fine-line improvement
Routes: Topical, Subcutaneous, Intranasal
Learn more
Recovery & RepairPreclinical

KPV

A potent anti-inflammatory tripeptide derived from alpha-melanocyte-stimulating hormone that reduces intestinal and systemic inflammation.

Reduces gut inflammation and SASP markersSuppresses pro-inflammatory cytokinesSupports intestinal barrier integrity
Routes: Oral, Subcutaneous, Intranasal
Learn more
Recovery & RepairEmerging

Larazotide Acetate

An octapeptide that restores intestinal tight junction integrity by antagonizing zonulin, the protein that regulates paracellular permeability.

Restores intestinal barrier functionReduces intestinal permeabilityDecreases symptom days by 26-31%
Routes: Oral
Learn more
Fat Loss & MetabolismEmerging

Retatrutide

A triple hormone receptor agonist (GIP/GLP-1/Glucagon) that produces 24% weight loss through synergistic appetite suppression and thermogenesis.

24% average weight loss (52 lbs / 24 kg)Superior lean mass preservation vs GLP-1 aloneEnhanced HbA1c reduction in diabetics
Routes: Subcutaneous
Learn more
Fat Loss & MetabolismApproved

Tirzepatide

FDA-approved dual GIP/GLP-1 agonist producing 22.5% weight loss—the highest ever recorded in an anti-obesity medication trial.

22.5% average weight loss at 15 mg75% fat loss, 25% lean mass (superior body composition)Superior HbA1c control vs semaglutide
Routes: Subcutaneous
Learn more
Fat Loss & MetabolismPreclinical

5-Amino-1MQ

A selective NNMT inhibitor that preserves cellular NAD+ to enhance metabolic rate and reduce fat accumulation.

35-40% reduction in fat mass (animal models)Increased resting energy expenditureImproved insulin sensitivity and glucose tolerance
Routes: Oral, Subcutaneous
Learn more
Fat Loss & MetabolismEmerging

MOTS-c

An exercise mimetic peptide derived from mitochondrial DNA that activates AMPK to restore insulin sensitivity and boost metabolic rate.

Restores insulin sensitivity to young-animal levelsIncreased mitochondrial biogenesisEnhanced exercise capacity
Routes: Subcutaneous
Learn more
Fat Loss & MetabolismPreclinical

SLU-PP-332

A pan-agonist of estrogen-related receptors (ERRα/β/γ) that induces the aerobic exercise gene program and increases energy expenditure.

Induces exercise gene program without activityIncreased energy expenditureEnhanced fatty acid oxidation
Routes: Oral (preclinical), Subcutaneous (preclinical)
Learn more
Growth HormoneEmerging

CJC-1295

A GHRH analog with a DAC modification that extends half-life, enabling once or twice-weekly dosing for sustained GH elevation.

2-10 fold GH elevation sustained 6+ days1.5-3 fold IGF-I elevationEnhanced muscle protein synthesis
Routes: Subcutaneous
Learn more
Growth HormoneEmerging

Ipamorelin

The first selective growth hormone secretagogue with no cortisol stimulation—a critical safety advantage over other GHRPs.

Pulsatile GH release (physiologic pattern)No cortisol or prolactin elevationEnhanced muscle protein synthesis
Routes: Subcutaneous
Learn more
Growth HormoneApproved

Tesamorelin

The only FDA-approved GHRH analog with proven efficacy for visceral fat reduction—uniquely selective for abdominal fat compartments.

15-18% visceral fat reduction33% hepatic steatosis reductionPreserved subcutaneous fat
Routes: Subcutaneous
Learn more
Longevity & CellularApproved

SS-31 (Elamipretide)

FDA-approved (2025) mitochondrial-targeted antioxidant that restores ATP production by stabilizing cardiolipin in the inner mitochondrial membrane.

Restored mitochondrial ATP productionReduced mitochondrial ROSImproved cellular energy status
Routes: Intravenous, Subcutaneous
Learn more
Longevity & CellularEmerging

Epithalon

A telomerase-activating peptide that extends telomeres and reverses senescence markers—backed by 25+ years of clinical use in Russia.

Measurable telomere lengtheningReversal of replicative senescenceRestored melatonin secretion
Routes: Subcutaneous, Intramuscular
Learn more
Longevity & CellularEmerging

Pinealon

A neuroprotective peptide bioregulator that enhances cognitive function and supports aging brain health through MAPK/ERK signaling.

Enhanced memory acquisition and retentionImproved attention and concentrationAccelerated reaction time
Routes: Subcutaneous, Intramuscular, Oral
Learn more
Longevity & CellularEmerging

NAD+ / NAD+ Precursors

Essential mitochondrial cofactor that declines with age. Supplementation enhances energy metabolism, DNA repair, and sirtuin activation.

Enhanced ATP productionSirtuin activation (longevity pathways)Improved mitochondrial function
Routes: Intravenous (NAD+), Subcutaneous (NAD+), Oral (NMN, NR)
Learn more
Longevity & CellularPreclinical

FOXO4-DRI

The first rationally designed senolytic peptide that selectively eliminates senescent cells by disrupting FOXO4-p53 interaction.

Selective senescent cell eliminationReduced SASP inflammatory cytokinesImproved tissue homeostasis (preclinical)
Routes: Intravenous, Subcutaneous (experimental)
Learn more
Vascular & Sexual HealthApproved

Tadalafil

FDA-approved PDE5 inhibitor that improves endothelial function and vascular health. Recent studies show 56% mortality reduction and cardiovascular protection.

56% reduction in all-cause mortality37% reduction in heart attack risk35% reduction in stroke risk
Routes: Oral
Learn more